Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Seminars in Arthritis and Rheumatism|June 12, 2026
The OMERACT core domain sets for calcium pyrophosphate deposition diseaseNicola Dalbeth, Yiling Zhang, Owen Hensey, et al.
Rheumatology (Oxford, England)|January 31, 2020
Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locusFaseeh Zaidi, Ravi K Narang, Amanda Phipps-Green, et al.
Seminars in Arthritis and Rheumatism|March 4, 2025
Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensusYiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Seminars in Arthritis and Rheumatism|November 29, 2021
Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working groupMelanie Birger Morillon, Robin Christensen, Jasvinder A Singh, et al.
Seminars in Arthritis and Rheumatism|March 14, 2025
Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensusYiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Journal of Thrombosis and Haemostasis : JTH|February 1, 2022
Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxisSarah Kelliher, Luisa Weiss, Sarah Cullivan, et al.
The Journal of Rheumatology|May 3, 2020
Flare Rate Thresholds for Patient Assessment of Disease Activity States in GoutWilliam Taylor, Nicola Dalbeth, Kenneth G Saag, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 22, 2017
Brief Report: Validation of a Definition of Flare in Patients With Established GoutAngelo L Gaffo, Nicola Dalbeth, Kenneth G Saag, et al.
Pageof 9